Trump’s proposed 2027 defense budget surge lifted Northrop Grumman (NOC) and peers briefly. Read more macro analysis here.
PHAT remains a Hold as VOQUEZNA revenue ramps and opex improves, but leverage, dilution and valuation risk persist.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback